Anbio Biotechnology (NNNN)
(Delayed Data from NSDQ)
$51.06 USD
+5.01 (10.88%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $51.10 +0.04 (0.08%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Anbio Biotechnology has a market cap of $6.63B, which represents its share price of $46.05 multiplied by its outstanding shares number of 143.89M. As a mid-cap company, NNNN's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NNNN 51.06 +5.01(10.88%)
Will NNNN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NNNN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NNNN
Anbio Biotechnology (NNNN) Launches Rapid Diagnostic Tools for Chikungunya and Respiratory ...
Anbio Biotechnology (NNNN) Launches Rapid Diagnostic Tools for Chikungunya and Respiratory ...
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute ...
12 Health Care Stocks Moving In Tuesday's Intraday Session
Anbio Biotechnology (NNNN) Shares Plummet Over 20% | NNNN Stock News